<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32-vaccines-08-00306">
 <label>32.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mosaheb</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Reiser</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Wetzler</surname>
    <given-names>L.M.</given-names>
   </name>
  </person-group>
  <article-title>Toll-like receptor ligand-based vaccine adjuvants require intact myd88 signaling in antigen-presenting cells for germinal center formation and antibody production</article-title>
  <source>Front. Immunol.</source>
  <year>2017</year>
  <volume>8</volume>
  <fpage>225</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2017.00225</pub-id>
  <?supplied-pmid 28316602?>
  <pub-id pub-id-type="pmid">28316602</pub-id>
 </element-citation>
</ref>
